PCSK9 Inhibition Ameliorates Experimental Autoimmune Myocarditis by Reducing Th17 Cell Differentiation Through LDLR/STAT-3/ROR-γt Pathway
INTERNATIONAL IMMUNOPHARMACOLOGY（2023）
关键词
Proprotein convertase subtilisin kexin type 9 (PCSK9),Evolocumab,Myocarditis,Th17 cell differentiation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要